Correlation Between Kezar Life and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Kezar Life and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Conduit Pharmaceuticals.
Diversification Opportunities for Kezar Life and Conduit Pharmaceuticals
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Kezar and Conduit is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Kezar Life i.e., Kezar Life and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kezar Life and Conduit Pharmaceuticals
Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Conduit Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 13.44 times less risky than Conduit Pharmaceuticals. The stock trades about -0.19 of its potential returns per unit of risk. The Conduit Pharmaceuticals is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 0.95 in Conduit Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 0.60 from holding Conduit Pharmaceuticals or generate 63.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 54.55% |
| Values | Daily Returns |
Kezar Life Sciences vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Kezar Life Sciences |
| Conduit Pharmaceuticals |
Kezar Life and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kezar Life and Conduit Pharmaceuticals
The main advantage of trading using opposite Kezar Life and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Kezar Life vs. Cue Biopharma | Kezar Life vs. Tff Pharmaceuticals | Kezar Life vs. Eliem Therapeutics | Kezar Life vs. Inhibrx |
| Conduit Pharmaceuticals vs. Cue Biopharma | Conduit Pharmaceuticals vs. Tff Pharmaceuticals | Conduit Pharmaceuticals vs. Eliem Therapeutics | Conduit Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |